| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |